Research article Special Issues

The role of geometric features in a germinal center


  • The germinal center (GC) is a self-organizing structure produced in the lymphoid follicle during the T-dependent immune response and is an important component of the humoral immune system. However, the impact of the special structure of GC on antibody production is not clear. According to the latest biological experiments, we establish a spatiotemporal stochastic model to simulate the whole self-organization process of the GC including the appearance of two specific zones: the dark zone (DZ) and the light zone (LZ), the development of which serves to maintain an effective competition among different cells and promote affinity maturation. A phase transition is discovered in this process, which determines the critical GC volume for a successful growth in both the stochastic and the deterministic model. Further increase of the volume does not make much improvement on the performance. It is found that the critical volume is determined by the distance between the activated B cell receptor (BCR) and the target epitope of the antigen in the shape space. The observation is confirmed in both 2D and 3D simulations and explains partly the variability of the observed GC size.

    Citation: Zishuo Yan, Hai Qi, Yueheng Lan. The role of geometric features in a germinal center[J]. Mathematical Biosciences and Engineering, 2022, 19(8): 8304-8333. doi: 10.3934/mbe.2022387

    Related Papers:

    [1] Kento Okuwa, Hisashi Inaba, Toshikazu Kuniya . An age-structured epidemic model with boosting and waning of immune status. Mathematical Biosciences and Engineering, 2021, 18(5): 5707-5736. doi: 10.3934/mbe.2021289
    [2] Sarita Bugalia, Jai Prakash Tripathi, Hao Wang . Mathematical modeling of intervention and low medical resource availability with delays: Applications to COVID-19 outbreaks in Spain and Italy. Mathematical Biosciences and Engineering, 2021, 18(5): 5865-5920. doi: 10.3934/mbe.2021295
    [3] Mengshi Shu, Rui Fu, Wendi Wang . A bacteriophage model based on CRISPR/Cas immune system in a chemostat. Mathematical Biosciences and Engineering, 2017, 14(5&6): 1361-1377. doi: 10.3934/mbe.2017070
    [4] Yendry N. Arguedas, Mario Santana-Cibrian, Jorge X. Velasco-Hernández . Transmission dynamics of acute respiratory diseases in a population structured by age. Mathematical Biosciences and Engineering, 2019, 16(6): 7477-7493. doi: 10.3934/mbe.2019375
    [5] Jinhu Xu, Yicang Zhou . Bifurcation analysis of HIV-1 infection model with cell-to-cell transmission and immune response delay. Mathematical Biosciences and Engineering, 2016, 13(2): 343-367. doi: 10.3934/mbe.2015006
    [6] Sharmin Sultana, Gilberto González-Parra, Abraham J. Arenas . Dynamics of toxoplasmosis in the cat's population with an exposed stage and a time delay. Mathematical Biosciences and Engineering, 2022, 19(12): 12655-12676. doi: 10.3934/mbe.2022591
    [7] Sarafa A. Iyaniwura, Rabiu Musa, Jude D. Kong . A generalized distributed delay model of COVID-19: An endemic model with immunity waning. Mathematical Biosciences and Engineering, 2023, 20(3): 5379-5412. doi: 10.3934/mbe.2023249
    [8] Kai Zhang, Xinwei Wang, Hua Liu, Yunpeng Ji, Qiuwei Pan, Yumei Wei, Ming Ma . Mathematical analysis of a human papillomavirus transmission model with vaccination and screening. Mathematical Biosciences and Engineering, 2020, 17(5): 5449-5476. doi: 10.3934/mbe.2020294
    [9] Georgi Kapitanov, Christina Alvey, Katia Vogt-Geisse, Zhilan Feng . An age-structured model for the coupled dynamics of HIV and HSV-2. Mathematical Biosciences and Engineering, 2015, 12(4): 803-840. doi: 10.3934/mbe.2015.12.803
    [10] Mohammed Meziane, Ali Moussaoui, Vitaly Volpert . On a two-strain epidemic model involving delay equations. Mathematical Biosciences and Engineering, 2023, 20(12): 20683-20711. doi: 10.3934/mbe.2023915
  • The germinal center (GC) is a self-organizing structure produced in the lymphoid follicle during the T-dependent immune response and is an important component of the humoral immune system. However, the impact of the special structure of GC on antibody production is not clear. According to the latest biological experiments, we establish a spatiotemporal stochastic model to simulate the whole self-organization process of the GC including the appearance of two specific zones: the dark zone (DZ) and the light zone (LZ), the development of which serves to maintain an effective competition among different cells and promote affinity maturation. A phase transition is discovered in this process, which determines the critical GC volume for a successful growth in both the stochastic and the deterministic model. Further increase of the volume does not make much improvement on the performance. It is found that the critical volume is determined by the distance between the activated B cell receptor (BCR) and the target epitope of the antigen in the shape space. The observation is confirmed in both 2D and 3D simulations and explains partly the variability of the observed GC size.



    Sustained oscillations in the number of infections have been observed for some infectious diseases. A classic example is the highly regular biennial pattern in measles case numbers in England and Wales from 1950 to 1967 (depicted in Fine and Clarkson, 1982 [1]), which is driven by a combination of births and seasonality of transmission related to the opening of school terms.

    Mathematically, sustained oscillations can be demonstrated by relatively simple models. Such models focus on a key mechanism such as seasonality in transmission (Aron and Schwartz, 1984 [2]), births and vaccinations (Earn et al., 2000 [3]), pathogen evolution through time scale separation of within and between season dynamics (Andreasen, 2003 [4]) or in combination with seasonality forcing (Dushoff et al., 2004 [5]), changes in human social behavior (d'Onofrio and Manfredi, 2009 [6]), importations of infectious individuals (Silva and Monteiro, 2014 [7]), heterogeneity in transmission due to chronological age (Kuniya and Inaba, 2023 [8] in this special issue) and change in behavior of healthy individuals due to social pressure (Baccili and Monteiro, 2023 [9]). These mechanisms can drive a surge in infections through three main methods: (i) replenishment of susceptible individuals, (ii) replenishment of infectious individuals and (iii) variation of the transmission parameter. Sustained oscillations are possible in these models for certain choices of parameter values.

    We argue that waning immunity is also a mechanism that can, by itself, produce sustained oscillations in infection numbers. For diseases with waning immunity, previous infection or vaccination only confers a temporary period of full protection against reinfection. The duration of protection ranges from a few weeks or months for the Omicron variant of SARS-CoV-2 (Burkholz et al., 2023 [10] and Bobrovitz et al., 2023 [11]), to possibly a few years for pertussis (Wendelboe et al., 2005 [12]). As fully immune individuals wane, more individuals become susceptible to infection and more infections occur. Eventually, fewer susceptibles remain and the number of infections falls. When new individuals lose full immunity, replenishment of susceptibles occurs and the cycle repeats.

    Here, we present a discrete-time waning immunity model (SIRWY model) that features the aforementioned loss of full immunity as a general population waning distribution, where the proportion of fully immune individuals who wane can be specified on a daily basis. In this Susceptible-Infectious-Immune-Waned-Infectious (SIRWY) model, S and I represent susceptible and infectious individuals without prior immunity, R represents fully immune individuals and W and Y represent waned (susceptible) and infectious individuals with prior immunity.

    A special case of SIRWY is the Susceptible-Infectious-Recovered-Susceptible (SIRS) model with geometric distributions for waning and recovery. This is the discrete-time counterpart to the continuous-time classic SIRS model with exponential distributions (Hethcote, 1976 [13]):

    dSdt=ωRβSIdIdt=βSIγIdRdt=γIωR. (1.1)

    In these equations, ω is the waning rate, β is the transmission rate per infectious individual and γ is the recovery rate. For all parameter values, the number of infections either tends to zero or the endemic equilibrium via exponential decay or damped oscillations (see Hethcote, 1976 [13] or a different proof in §6 of this paper). A variation of the classic SIRS is the SIR1...RnS model with Erlang distribution (sum of exponentials), in which individuals wait in the additional immune sub-compartments before becoming susceptible. It has been shown that sustained oscillations are possible for the SIR1...RnS model when n3 (Hethcote et al., 1981 [14]). In this paper, we show that the discrete-time version of SIRS with geometric distributions can generate undamped oscillations, and the oscillatory regime disappears when discrete-time tends to continuous-time.

    A different special case of SIRWY is one with homogeneous waning and recovery distributions. This model has fixed waning and recovery times, in which individuals spend exactly the same number of days fully immune and are infectious for exactly same number of days if infected. Due to this fixed delay in terms of time spent in the immune compartment, surges in susceptibles occur at fixed intervals. We show that sustained oscillations can be produced, similar to continuous-time models with delays (Hethcote et al., 1981 [14], Diekmann and Montijn, 1982 [15] and Kyrychko and Blyuss, 2005 [16]).

    Besides having a general waning distribution, the full SIRWY model features another effect of waning immunity, the loss of partial immunity, which also contributes to oscillatory dynamics. After losing full immunity, individuals still have partial immunity that reduces their susceptibility to reinfection and potentially also their infectiousness if infected. However, partial immunity wanes over time and individuals become more susceptible and infectious. The accumulation of susceptibility and infectiousness in the population leads to a surge in infections. Similar to the loss of full immunity, this results in a cyclical pattern in infection numbers.

    While waning immunity is a mechanism that can generate oscillations, it does not always do so as it depends on the choice of waning immunity effects (losses of full and partial immunity) and how exactly these effects are represented in the model (discrete/continuous time, population waning distribution, changes in susceptibility and infectiousness over time). As a general model which also encompasses different simpler sub-models, SIRWY allows an appropriate model to be chosen based on what is currently known about the infectiousness of the disease and the effects of waning immunity in the population, before scaling up to the full model when needed. Furthermore, for model implementation, discrete-time SIRWY is a system of difference equations, which makes numerical simulations easier to perform as compared with integro-differential equations in continuous-time.

    The rest of this paper is structured as follows. We start by presenting the Susceptible-Infectious-Immune-Waned-Infectious (SIRWY) model in §2, before presenting a stability analysis about the disease-free and endemic equilibria in §3. We then proceed to recover two sub-models of the SIRWY model, one with fixed waning and recovery times in §4 and another with geometric distributions for waning and recovery in §5. For these sub-models, we perform bifurcation analysis, on top of the stability analyses about the disease-free and endemic equilibria. We then study the continuous-time exponential SIRS model (equation 1.1) in §6, before making the connection between this model and its discrete-time counterpart in §7 to show that the oscillatory regime disappears in continuous-time.

    Since our goal is to understand how waning immunity shapes the long term dynamics of a disease, we consider a population comprising individuals with some degree of immunity because all individuals would have been infected at least once in the long run. Furthermore, as the focus is on waning immunity, other mechanisms that replenish susceptibles such as births are not included (similar to how the evolutionary model is constructed in Pease, 1987 [17]). Since we are also not considering pathogen evolution, this means that all properties of the disease related to infection, recovery and waning of immunity are unchanged over extended periods. Let Rt, Wt and Yt denote the proportions of the population who are in the fully immune, waned and infectious compartments respectively on day t. Here, we always discuss in terms of proportions of population in each compartment rather than exact numbers. For completeness, we give the full Susceptible-Infectious-Immune-Waned-Infectious (SIRWY) model in Appendix 12 but our focus is on the Immune-Waned-Infectious (RWY) model (Figure 1) for the rest of the paper.

    Figure 1.  Immune-Waned-Infectious (RWY) model for a population with prior immunity.

    Each compartment in the model (R, W and Y) is further divided into sub-compartments based on time since most recent recovery τ (first introduced by Kermack and McKendrick, 1932 [18]) with respect to day t. For example, Rt,τ denotes the proportion of population in the immune R compartment on day t and day τ since recovery. In this notation, we can deduce the day of recovery by subtracting the second subscript from the first subscript (day tτ for Rt,τ).

    The use of time since recovery τ allows us to track the total number of days an individual spends in the R, W and Y compartments. Time since recovery τ starts from day 0 when the individual first joins the R compartment and increases with the day as the individual progresses through the waned W and infectious Y compartments. The value of τ then resets to 0 when the individual rejoins the R compartment (see Figure 2 for an example). This formulation tracks a full RWY cycle (RWYR), not just the time spent in each compartment (Inaba, 2001 [19]).

    Figure 2.  Example of how an individual moves between compartments. The second component of the subscript is the time since recovery τ, which starts from 0, increases and then resets to 0 when the individual rejoins the R compartment. Subtracting the second subscript from the first subscript gives the day of recovery t.

    We cover the entire immune spectrum as we have the fully immune R compartment and the waned W and infectious Y compartments with partial immunity based on each day τ since recovery. We do not have the fully susceptible S in the RWY model but it is present in the full SIRWY model. The R compartment represents full immunity against infection, unlike that in Kermack and McKendrick (1932) [18], where R individuals are partially susceptible to infection. Partial immunity provides a reduction in susceptibility ατ of waned W individuals and a reduction in infectiousness χτ of infectious Y individuals. Since the susceptibility of waned individuals depends on the time since recovery τ, there is no need to use the method of stages to partition susceptibles into a fixed number of sub-compartments S1, S2, ..., Sn with n different susceptibilities.

    The RWY model, along with a summary of terms in Table 1, is described by the following system of difference equations,

    Rt+1,0=¯θθ=0(ϕθϕθ+1)ytθRt+1,τ=ζτRt(τ1),0for τ{1,,¯τ}Wt+1,1=(ζ0ζ1)Rt,0Wt+1,τ=Wt,τ1yt+1,τ+(ζτ1ζτ)Rt(τ1),0for τ{2,,¯τ+1}Wt+1,τ=Wt,τ1yt+1,τfor τ{¯τ+2,,˜τ1}Wt+1,˜τ=Wt,˜τ1+Wt,˜τyt+1,˜τFt=¯θθ=0˜ττ=2ξθϕθytθ,τ(1χτ)yt+1,τ=(1ατ1)Wt,τ1Ftfor τ{2,,˜τ1}yt+1,˜τ=[(1α˜τ1)Wt,˜τ1+(1α˜τ)Wt,˜τ]Ft (2.1)
    Table 1.  Variables, indices and parameters of the RWY model.
    Symbol Variable Symbol Index Symbol Parameter
    R immune θ time since infection ϕθ fraction still infectious
    W waned ¯θ+1 max infectious period ξθ infectiousness
    y newly infected τ time since recovery ζτ fraction still immune
    Y infectious ¯τ+1 max immune period χτ reduction in infectiousness
    F force of infection ˜τ max value of τ ατ reduction in susceptibility

     | Show Table
    DownLoad: CSV

    and the conservation of individuals means that

    Rt+Wt+Yt=1. (2.2)

    Each compartment (R, W and Y) can be defined in terms of their corresponding sub-compartments (see Table 2).

    Table 2.  Definition of variables in the RWY model. The indices t, τ and θ refer to the time, time since recovery and time since infection respectively. The summations correspond to the max immune period (¯τ+1), the max value of τ (˜τ) and the max infectious period (¯θ+1).
    Symbol Variable Composition
    Rt immune Rt=¯ττ=0Rt,τ or Rt=¯ττ=0ζτRtτ,0
    Wt waned Wt=˜ττ=1Wt,τ
    Yt infectious Yt=˜ττ=2Yt,τ or Yt=¯θθ=0ϕθytθ
    yt newly infected yt=˜ττ=2yt,τ

     | Show Table
    DownLoad: CSV

    In the RWY model (equation 2.1), the newly infected y is used instead of the infectious Y because the infectious Yt=¯θθ=0ϕθytθ can be expressed in terms of newly infected y at time t and earlier times, with ϕθ representing the fraction of ytθ still infectious on day θ since infection (as similarly defined by Kermack and McKendrick, 1927 [20]). Here, ϕ0=1 because all infecteds would have just joined the infectious compartment the same day they became infected, which is day 0 since infection. By defining the maximum allowable infectious period to be ¯θ+1 days, the fraction still infectious ϕθ=0 for θ¯θ+1 and the infectious Yt is expressed in terms of newly infecteds yt¯θ to yt.

    The force of infection Ft has contributions from the fraction ϕθ of newly infecteds ytθ,τ who are still infectious on day θ since infection. On day t, each of these individuals contributes a baseline infectiousness ξθ based on the time since infection θ, which is then reduced by a factor of χτ. Here, the τ in both χτ and ytθ,τ refers to the number of days since recovery with respect to the day of infection tθ and not with respect to day t. As the maximum infectious period is ¯θ+1 days, infectiousness ξθ=0 for θ¯θ+1.

    Individuals who recover on day t+1 join the newly recovered Rt+1,0 immune compartment. Using the fraction still infectious ϕθ, we define the population recovery distribution ϕθϕθ+1, which gives the proportion of newly infected ytθ who recover on day θ+1 since infection.

    We define the immune Rt in a similar way as the infectious Yt. Here, Rt=¯ττ=0ζτRtτ,0, where ζτ represents the fraction of newly recovered Rtτ,0 still immune on day τ since recovery. Again, ζ0 is equals to 1 because all individuals would have just joined the immune compartment the day they recover. By defining the maximum allowable immune period to be ¯τ+1 days, the fraction still immune ζτ=0 for τ¯τ+1 and the immune Rt only consists of newly recovereds Rt¯τ,0 to Rt,0. Since individuals can only remain in the immune compartment for ¯τ+1 days and the immune compartment is the first compartment individuals join after recovery, we can express Rt=¯ττ=0Rt,τ in terms of its sub-compartments Rt,τ, with the final term being Rt,¯τ as Rt,τ=0 for τ¯τ+1. Using the fraction still immune ζτ, we define the population waning distribution ζτ1ζτ, which gives the proportion of newly recovered Rt(τ1),0 who wane on day τ since recovery.

    The waned Wt and newly infected yt can also be expressed in terms of their sub-compartments. For the waned on day t, Wt,τ starts from Wt,1 rather than Wt,0 because individuals are assumed to spend at least one day in the immune compartment before moving to the waned compartment. By the same reasoning, yt,τ starts from yt,2 because individuals are assumed to spend at least another day in the waned compartment. By defining a maximum value of τ=˜τ, we have Wt=˜ττ=1Wt,τ and yt=˜ττ=2yt,τ, where the final terms Wt,˜τ and yt,˜τ comprise all waned and newly infecteds individuals respectively with τ˜τ. We may also define the infectious Yt=˜ττ=2Yt,τ, in terms of its sub-compartments Yt,τ, where Yt,˜τ comprises all infectious individuals with τ˜τ.

    The waning of partial immunity is a decrease in protection, which is equivalent to decreases in the value of the reduction in susceptibility ατ and potentially also the reduction in infectiousness χτ as τ increases. As we are using a maximum value of τ=˜τ, the reduction in susceptibility ατ reaches a constant value α˜τ for τ˜τ and the reduction in infectiousness χτ a constant value χ˜τ for τ˜τ. Together with the population waning distribution ζτ1ζτ, these three features specify how the losses of full and partial immunity are modeled in the RWY model.

    We conclude this section by remarking that we have intentionally made a linear approximation on how the newly infected yt depends on the force of infection Ft (Hernandez-Ceron et al., 2013 [21], Diekmann et al., 2021 [22]). The full description is the following:

    yt+1,τ=(1ατ1)Wt,τ1(1eFt)for τ{2,,˜τ1}yt+1,˜τ=[(1α˜τ1)Wt,˜τ1+(1α˜τ)Wt,˜τ](1eFt). (2.3)

    This form, however, cannot be utilized easily as Ft is also a function of newly infected yt at earlier times. As long as the force of infection Ft is not too large, we can work with the linearized equation (2.1) to perform stability analysis. Equation 2.1 also allows for efficient numerical simulations to be performed via matrix-vector multiplications.

    In this section, we derive the model equations (equation 2.1) at steady state. Letting time tend to infinity and using to denote the steady state, the immune R equations become

    R,0=yR,τ=ζτyfor τ{1,,¯τ} (3.1)

    after substituting ¯θθ=0(ϕθϕθ+1)=1. Adding the equations in (3.1), the proportion of recovered individuals in the population at steady state is

    R=y¯ττ=0ζτ, (3.2)

    where we have used ζ0=1. Performing a similar analysis on the waned equations, we get:

    W,1=(ζ0ζ1)yW,τ=W,τ1y,τ+(ζτ1ζτ)yfor τ{2,,¯τ+1}W,τ=W,τ1y,τfor τ{¯τ+2,,˜τ1}W,˜τ1=y,˜τ, (3.3)

    where we have substituted R,0=y. The waned equations can also expressed in terms of y and its components:

    W,1=(ζ0ζ1)yW,τ=˜τk=τ+1y,kζτyfor τ{2,,¯τ}W,τ=˜τk=τ+1y,kfor τ{¯τ+1,,˜τ1}. (3.4)

    Note that in the above analysis, we do not have an expression for W,˜τ yet. The steady state equations for the force of infection and newly infectious are:

    F=¯θθ=0ξθϕθ˜ττ=2y,τ(1χτ)y,τ=(1ατ1)W,τ1Ffor τ{2,,˜τ1}y,˜τ=[(1α˜τ1)W,˜τ1+(1α˜τ)W,˜τ]F. (3.5)

    Since Yt=¯θθ=0ϕθytθ, the infectious proportion of population at steady state is

    Y=y¯θθ=0ϕθ. (3.6)

    The steady state equations above will be used to derive the disease-free and endemic equilibria in the sub-sections that follow.

    We derive the disease-free equilibrium by setting the newly infected proportion of the population y,τ to be zero for all τ in the steady state equations 3.1, 3.4 and 3.5. By the conservation of individuals (equation 2.2), we find that in the disease-free equilibrium, all individuals end up in the waned W,˜τ compartment, with

    y,τ=0for τ{2,,˜τ}W,τ=0for τ{1,,˜τ1}W,˜τ=1. (3.7)

    We now proceed to set up a vector system of the model for linear stability analysis about the disease-free equilibrium. Let xt+1=g(xt), where xt is a vector that is formed by the newly infected yt¯τ¯θ to yt and the waned Wt. Here, g is a function to be specified using the model equations (2.1 and 2.2).

    Linearizing about the disease-free equilibrium and performing elementary column operations on JλI (where J is the Jacobian for the model equations evaluated at the disease-free equilibrium), we obtain the following characteristic equation:

    λ(¯τ+¯θ+2)(˜τ1)¯θ[λ¯θ+1(1α˜τ)(1χ˜τ)¯θk=0ξkϕkλ¯θk]=0. (3.8)

    Theorems related to the zeroes of polynomial are discussed in Appendix B. Using Theorem B.6 and Lemma B.7, we find that the disease-free equilibrium is asymptotically stable if and only if R0<1, where the modified basic reproductive ratio is defined as R0=(1α˜τ)(1χ˜τ)¯θk=0ξkϕk. Note that R0<1 is the explicit threshold for all solutions to tend towards the disease-free equilibrium. Here, R0 is a modified basic reproductive ratio because α˜τ and χ˜τ are not necessary zero, in particular, waned W individuals at τ=˜τ may still be less susceptible to infection than susceptible S individuals.

    There are two key observations. First, R0 depends on the reductions in infectiousness χτ and susceptibility ατ only when τ=˜τ and not earlier values of τ. This is because earlier values of τ are transient and hence not present in the steady disease-free equilibrium. The only value of τ that has a lasting effect is when τ takes the maximum value of ˜τ because τ remains at this value thereafter even as the day increases. Second, R0 is independent of population recovery distribution ϕθϕθ+1 and population waning distribution ζτ1ζτ (see equation 2.1). Again, this is because recovery takes place for a maximum allowable period of ¯θ+1 days (infectious period) and waning for a maximum allowable period of ¯τ+1 days (immune period), which are transient periods that do not continue until τ=˜τ.

    For the endemic equilibrium, an explicit form is difficult to obtain because the steady state equations (3.1, 3.4 and 3.5) are non-linear in y,τ. We can make progress in the special case where the reduction in susceptibility and infectiousness are independent of τ, namely, ατ=α and χτ=χ respectively. Then, the force of infection and the newly infected (equation 3.5) can be simplified to:

    F=(1χ)y¯θθ=0ξθϕθy,τ=R0yW,τ1for τ{2,,˜τ1}y,˜τ=R0y(W,˜τ1+W,˜τ), (3.9)

    where we have substituted R0=(1χ)(1α)¯θθ=0ξθϕθ defined earlier. Summing up the y,τ equations, we get W=1R0. Substituting this equation along with equations 3.2 and 3.6 into R+W+Y=1, we obtain an expression for y:

    y=R01R0(¯ττ=0ζτ+¯θθ=0ϕθ). (3.10)

    The term in brackets is the sum of the fraction of newly recovered who remain immune and the fraction of newly infecteds who remain infectious throughout the entire immune and infectious period respectively. Clearly, y exists (is greater than zero) if and only if R0 is greater than one. Now, W and y are completely defined in terms of parameter values. Using W=˜ττ=1W,τ, equation 3.4 and W=1R0, we can express W,˜τ in terms of y,τ:

    W,˜τ=1R0+y¯ττ=1ζτ˜ττ=2˜τj=τy,j. (3.11)

    This equation, along with equations 3.9 and 3.3, allow us to obtain a closed form for the endemic equilibrium:

    y,τ=R0y2min(τ2,¯τ)k=0(ζkζk+1)(1R0y)τ2kfor τ{2,,˜τ1}y,˜τ=y¯τk=0(ζkζk+1)(1R0y)˜τ2kW,τ=ymin(τ1,¯τ)k=0(ζkζk+1)(1R0y)τ1kfor τ{1,,˜τ1}W,˜τ=1R0+y¯ττ=1ζτ(˜τ1)y¯τk=0(ζkζk+1)(1R0y)˜τ2kR0y2˜τ1τ=2˜τ1j=τmin(j2,¯τ)k=0(ζkζk+1)(1R0y)j2k. (3.12)

    In this case, the endemic equilibrium is uniquely defined. Proceeding, we perform stability analysis for the simplest case (˜τ=3, ¯τ=1 and ¯θ=1). Here, R0=(1χ)(1α)(ξ0ϕ0+ξ1ϕ1). Equation 3.10 for y simplifies to y=R01R0(2+ϕ1+ζ1) and the endemic equilibrium (equation 3.12) is

    y,2=R0y2(ζ0ζ1)y,3=y[(ζ0ζ1)(1R0y)+ζ1]W,1=y(ζ0ζ1)W,2=y,3=y[(ζ0ζ1)(1R0y)+ζ1]W,3=1R0+yζ12y[(ζ0ζ1)(1R0y)+ζ1]R0y2(ζ0ζ1). (3.13)

    Performing elementary column operations on JλI (where J is the Jacobian for the model equations evaluated at the endemic equilibrium), we get the following characteristic equation:

    λ5(λ4+3s=0ksλs)=0, (3.14)

    where

    k3=(1α)(1χ)[1R0σ0+y(σ0+σ1)]k2=(1α)(1χ)[1R0σ1+y(σ0+σ1)]k1=[ϕ1+ζ1(1ϕ1)]R0yk0=ζ1ϕ1R0y. (3.15)

    Here, we have used the short-form σθ=ξθϕθ. Using Theorem B.6, we obtain sufficient conditions for the endemic equilibrium to be asymptotically stable. Depending on the sign of k2 and k3, there are four different cases to consider:

    1. For k2<0 and k3>0, i.e., 1+2+ϕ1+ζ1σ0+σ1σ0<R0<1+2+ϕ1+ζ1σ0+σ1σ1,

    the condition for stability is R0<1+2σ0(2+ϕ1+ζ1)(σ0+σ1)(ϕ1+ζ1).

    2. For k2>0 and k3<0, i.e., 1+2+ϕ1+ζ1σ0+σ1σ1<R0<1+2+ϕ1+ζ1σ0+σ1σ0,

    the condition for stability is R0<1+2σ1(2+ϕ1+ζ1)(σ0+σ1)(ϕ1+ζ1).

    3. For k2>0 and k3>0, i.e., R0>1+2+ϕ1+ζ1σ0+σ1max(σ0,σ1),

    the condition for stability is R0<3.

    4. For k2<0 and k3<0, i.e., R0<1+2+ϕ1+ζ1σ0+σ1min(σ0,σ1),

    the condition for stability is ϕ1+ζ1<2.

    Using Lemma B.7, the necessary conditions for the endemic equilibrium to be asymptotically stable are:

    1. R0<1+2+ϕ1+ζ1ζ1ϕ1

    2. R0<1+2σ0(2+ϕ1+ζ1)(σ0+σ1)(ϕ1+ζ12ζ1ϕ1) if ζ1ϕ1<12(ϕ1+ζ1)

    R0>1+2σ0(2+ϕ1+ζ1)(σ0+σ1)(ϕ1+ζ12ζ1ϕ1) if ζ1ϕ1>12(ϕ1+ζ1).

    Unlike the case for the disease-free equilibrium, the sufficient and necessary conditions here do not together provide equivalence conditions for asymptotic stability. As such, we do not have explicit thresholds for the solutions to be in the endemic equilibrium regime. This is similar to models with varying delays in continuous-time, in which sufficient conditions for the endemic equilibrium regime are obtained (Stech and Williams, 1981 [23]) or numerical bifurcation analysis is performed (Blyuss and Kyrychko, 2010 [24]).

    We consider the case where every individual follows exactly the same waning and recovery trajectory. Infected individuals join the immune compartment on day ¯θ+1 since infection and recovered individuals join the waned compartment on day ¯τ+1 since recovery. Similar to how classic SIRS is formulated, we consider the simplest model by dropping the dependence on time since infection θ and time since recovery τ, arriving at a constant value of infectiousness ξ, reduction in susceptibility α and reduction in infectiousness χ. The RWY model (equation 2.1) becomes:

    Rt+1=Rt+yt¯θyt¯τ¯θ1Wt+1=Wtyt+1+yt¯τ¯θ1yt+1=βWt¯θθ=0ytθ, (4.1)

    where β=ξ(1χ)(1α). Note that the proportions of the population in the sub-compartments yt+1,τ and Wt+1,τ are no longer needed to be considered individually as they have been summed up. In addition, from the RWY model (equation 2.1), we get Rt+1,0=yt¯θ and Rt=¯θ+¯τ+1θ=¯θ+1ytθ. Substituting the latter expression and Wt=1RtYt into the last equation of (4.1), we obtain a non-linear scalar equation:

    yt+1=β¯θθ=0ytθ(1¯θ+¯τ+1θ=0ytθ). (4.2)

    We linearize about the disease-free equilibrium by setting yt=ϵλt, where ϵ is small, to get the following characteristic equation:

    λ¯θ+1β¯θs=0λs=0. (4.3)

    By Theorem B.6 and Lemma B.7, the disease-free equilibrium is asymptotically stable if and only if R0<1, where R0=β(¯θ+1). The endemic equilibrium can be found using equation (4.2) to be y=R01R0(¯θ+¯τ+2), which is uniquely defined. Linearizing about the endemic equilibrium, we get the following characteristic equation:

    λt+1=2¯θ+¯τ+3β(¯θ+1)2(¯θ+1)(¯θ+¯τ+2)¯θθ=0λtθβ(¯θ+1)1¯θ+¯τ+2¯θ+¯τ+1θ=¯θ+1λtθ. (4.4)

    Applying Theorem B.6, the sufficient conditions for asymptotic stability are:

    1<R0<3and¯θ>¯τ. (4.5)

    The second condition requires the infectious period to be greater than the immune period for stability. This agrees with what other continuous-time models have found (Diekmann and Montijn, 1982 [15], Hethcote et al. (1981) [14] and Stech and Williams (1981) [23]): a long immune period can lead to instability of the endemic equilibrium. On the other hand, applying Lemma B.7, the necessary conditions for asymptotic stability are given by:

    1<R0<¯θ+¯τ+3. (4.6)

    Note that ¯θ+¯τ+3 is the minimum amount of time an individual spends going through the R (¯τ+1 days), W (1 day) and Y (¯θ+1 days) compartments before returning to the R compartment.

    To obtain explicit thresholds, we consider two special cases. Case 1: If the immune period is one day (¯τ=0), then using Theorem B.5, the endemic equilibrium is asymptotically stable if and only if equation (4.6) holds. Case 2: If the infectious period is one day (¯θ=0), then we use the Determinantal Criterion directly (Theorem B.3) for ¯τ=1, 2 and 3 to get 1<R0<52, 1<R0<522 and 1<R0<19554 respectively.

    We perform bifurcation analysis for these two cases. For case 1 (¯τ=0), at the critical value R0=¯θ+3, the endemic equilibrium loses stability. There are two sub-cases.

    1. For ¯θ odd, setting ¯θ=2n+1, the characteristic polynomial is λ2n+3+2n+12n+22n+2j=1λj+1. We apply Theorem (B.8) with a=2n+12n+2, and find that all eigenvalues lie on the unit circle. One of the eigenvalues is 1 and there are (n+1) complex conjugage pairs. A flip (also known as period doubling) and Neimark-Sacker bifurcation occur concurrently.

    2. For ¯θ even, setting ¯θ=2n, the characteristic polynomial is λ2n+2+2n2n+12n+1j=1λj+1. Again, applying Theorem (B.8) with a=2n2n+1, all eigenvalues lie on the unit circle and there are (n+1) complex conjugate pairs. A Neimark-Sacker bifurcation occurs.

    (a) If ¯θ=0, the eigenvalues are ±i, which leads to a 1:4 (also known as period 4) resonance, for which the constants b and d in the complex normal form can be computed using equations (C.11) and (C.12) to be 949i8 and 9i8 respectively.

    For case 2 (¯θ=0), for ¯τ=1 to 3, at the critical value of R0, we have a pair of complex conjugate eigenvalues with modulus 1, leading to a Neimark-Sacker bifurcation. There is no strong resonance for these eigenvalues found. The invariant expression d can be computed using equation (C.9) and they are all negative, which means that a stable closed invariant curve bifurcates from the fixed point for R0 greater than the critical value.

    Our analysis above for the RWY sub-model with fixed recovery and waning times implies that there are three dynamic regimes - (i) disease-free equilibrium, (ii) endemic equilibrium and (iii) oscillatory solutions due to flip or Neimark-Sacker bifurcations.

    We now consider geometric distributions for both recovery and waning. At the individual level, on each day, an infectious individual has a probability γ of recovering and a recovered individual has a probability ω of joining the waned compartment. At the population level, the fraction still infectious is ϕθ=(1γ)θ and the fraction still immune is ζτ=(1ω)τ. The R equations can thus be expressed as:

    Rt+1=τ=0(1ω)τ+1Rtτ,0+γθ=0(1γ)θytθ. (5.1)

    Note that both the immune period and the infectious period are infinite days long. Furthermore, if we assume that the infectiousness ξ, reduction in susceptibility α and reduction in infectiousness χ are constants, then the RWY model (using equations 2.1, 2.2 and 5.1) becomes:

    Rt+1=(1ω)Rt+γYtWt+1=Wt+ωRtβWtYtYt+1=(1γ)Yt+βWtYt, (5.2)

    where the transmission parameter β=ξ(1χ)(1α). Using the property of geometric distributions, we note that the mean number of days an individual stays in the infectious and immune compartments is 1γ and 1ω respectively. Such a model with geometric distributions is often described as 'memoryless' because the probabilities that an infectious individual remains infectious and an immune individual remains immune on a particular day do not depend on the number of days they have already spent in the infectious and immune compartments respectively.

    Substituting Rt=1YtWt and Wt=1βYt[Yt+1(1γ)Yt] into the second equation of (5.2), we obtain a scalar nonlinear difference equation:

    Yt+1=[(1ω)YtYt1βYt+ω(1γ+β)+β(1γω)Yt1]Yt. (5.3)

    We linearize about the disease-free equilibrium by letting Yt=ϵλt, where ϵ is small, and obtain the characteristic equation ω[λ(1γ+β)]=0. The disease-free equilibrium is asymptotically stable if and only if R0<1, where R0=βγ.

    From equation (5.3), the endemic equilibrium can be found to be Y=ω(βγ)β(ω+γ), which is uniquely defined. Linearizing about the endemic equilibrium, we get the characteristic equation λ2+p1λ+p0=0, where p1=2+ω+ω(βγ)ω+γ and p0=1ω+ω(βγ)(ω+γ1ω+γ). Using the Determinantal Criterion for order 2 (equation B.2), the endemic equilibrium is asymptotically stable if and only if

    1<R0<1+q, (5.4)

    where

    q={γ+ωγ(γ+ω1)if0<ω<1and44ω+ω24ω<γ<12(2ω)(γ+ω)γω(2γω)if0<ω<1and0<γ<44ω+ω24ω. (5.5)

    At the critical value R0=1+2(2ω)(γ+ω)γω(2γω), the eigenvalues are 1 and 2+(γ+ω)(3+ω)2+γ+ω. The latter eigenvalue cannot take the value 1 or 1 under the constraints for γ and ω. Hence, the Jacobian J has a simple critical eigenvalue 1 and a flip bifurcation occurs. The invariant formula b in the normal form of a flip bifurcation (equation C.6) can be calculated using the formula (equation C.7) to be

    b=(2+γ+ω)3[γ(1+ω)+(2+ω)ω][γ2ω+2(2+ω)ω+γ(4+ω2)]2[γ(4+ω)+(2+ω)2]3(2+ω)2ω2(γ+ω). (5.6)

    Under the constraints for γ and ω, b is always greater than 0, which means that a stable period two cycle bifurcates from the fixed point for R0>R0.

    On the other hand, at the critical value R0=1+γ+ωγ(γ+ω1), the eigenvalues are

    2γ(2+ω)+2ωω2±iω[γ2(4ω)(2+ω)2ω+2γ(2+4ωω2)]2(1+γ+ω), (5.7)

    which have modulus one under the constraints for γ and ω. Thus, a Neimark-Sacker bifurcation occurs at the critical value R0.

    Like the RWY sub-model with fixed recovery and waning times, our analysis here for the sub-model with geometric distributions in discrete-time implies that there are three dynamic regimes - (i) the disease-free equilibrium, (ii) the endemic equilibrium and (iii) oscillatory solutions due to flip or Neimark-Sacker bifurcation.

    We take the limit as time step tends to zero for the discrete-time sub-model with geometric distributions (equation 5.2), to get the continuous-time RWY model with exponential distributions:

    dRdt=ωR+γYdWdt=ωRβWYdYdt=γY+βWY, (6.1)

    where β is the transmission rate per infectious individual, ω is the waning rate and γ is the recovery rate. We present the following analysis in the same manner as earlier sections of the paper, and refer the reader to Hethcote, 1976 [13] for an alternative derivation of these results.

    The disease-free equilibrium is given by: R=0, W=1 and Y=0. It is asymptotically stable if and only if R0<1, where R0=βγ.

    The endemic equilibrium is given by: R=γ(βγ)β(ω+γ), W=γβ and Y=ω(βγ)β(ω+γ), which is uniquely defined. Note that the expression for the endemic equilibrium in continuous-time is the same as that in discrete-time. The eigenvalues of the Jacobian matrix are

    λ±=12[ˇω±ˇω24ωγ(R01)], (6.2)

    where ˇω=ω(ωγ+R0ωγ+1). The endemic equilibrium is asymptotically stable if and only if both eigenvalues are negative, which occurs if and only if R0>1. Hence, the RWY sub-model with exponential distributions in continuous-time only has two dynamic regimes: the disease-free equilibrium and the endemic equilibrium. No oscillatory solution is possible.

    In this section, we seek to understand how the dynamic regimes change when we transit from discrete-time to continuous-time. The discrete-time sub-model with geometric distributions with time step h is:

    Rt+1=(1hω)Rt+hγYtWt+1=Wt+hωRthβWtYtYt+1=(1hγ)Yt+hβWtYt, (7.1)

    which is almost identical to the discrete-time sub-model with geometric distributions (equation 5.2), except that each of the parameters ω, β and γ is scaled by h. By taking into account this factor h in previous results for the discrete-time model with a time step of one day, we see that as before, R0=βγ and the disease-free equilibrium is asymptotically stable if and only if R0<1. The endemic equilibrium also remains the same: R=γ(βγ)β(ω+γ), W=γβ and Y=ω(βγ)β(ω+γ). It is asymptotically stable if and only if 1<R0<1+qh, where

    qh={γ+ωγ(hγ+hω1)if0<ω<1hand44hω+h2ω2h(4hω)<γ<1h2(2hω)(γ+ω)hγω(2hγhω)if0<ω<1hand0<γ<44hω+h2ω2h(4hω). (7.2)

    In the limit as h tends to zero, the top case in equation 7.2 collapses and qh tends to infinity. Hence, the endemic equilibrium is asymptotically stable if and only if R0>1 and the last regime with flip/Neimark-Sacker bifurcation in discrete-time disappears (see Figure 3). The number of dynamic regimes decreases from three to two and oscillatory solutions are no longer possible.

    Figure 3.  Schematic of the stable long term dynamic regimes for the discrete-time Immune-Waned-Infectious (RWY) model with geometric distributions. As the time step h tends to zero, this model tends to its continuous classic SIRS and the regime with sustained oscillations disappears.

    We have intentionally chosen to focus on waning immunity to improve our understanding of the underlying mechanism behind the recent waves of COVID-19 infections in this ongoing pandemic. The emergence of new variants has often been invoked as the reason causing waves of surges in case numbers. However, our work shows that the waning of prior immunity, whether that immunity is from infection or vaccine, is sufficient on its own to drive oscillations. Hence, at least in theory, pathogen evolution may be purely consequential rather the cause of these waves.

    In practice, COVID-19 waves are unlikely to be driven by a single mechanism. The effects of phylodynamics (Grenfell et al., 2004 [25]) are complex and there is likely a feedback loop between waning immunity dynamics and pathogen evolution. However, we argue that for diseases with evidence of waning immunity, the loss of immunity should be considered to be a candidate for the main mechanism driving oscillatory dynamics. This is particularly true for diseases with a short temporary period of strong protection like COVID-19, where parsimonious waning immunity models can be used to explain the key trends of observed oscillations in case numbers.

    From the public health point of view, policy makers may want to know whether surges in case numbers will happen in the long term for endemic diseases with waning immunity. Surges in case numbers are particularly problematic if the disease has severe health outcomes, especially when healthcare capacity is a major constraint. Models can help by distinguishing between two model outcomes for endemic diseases – the endemic equilibrium and sustained oscillations. The former does not lead to long term surges in case numbers but the latter does. If waning immunity plays a role in sustaining oscillations, then understanding the population infection dynamics can help policy makers decide the timing of booster campaigns to reduce the size of future case surges.

    We thank the three anonymous reviewers for their useful feedback, which helped to improve this manuscript.

    Desmond Z. Lai is supported by the Trinity Hall Research Studentship and Cambridge International & Department of Applied Mathematics and Theoretical Physics (DAMTP) Scholarship. Julia R. Gog is supported by the JUNIPER partnership (MRC grant no MR/X018598/1).

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    All authors declare that there is no conflict of interest.

    The SIRWY model (see Figure 4) is an extension to the RWY model as it takes into account individuals in the population who do not have prior immunity to the disease. These individuals belong to either the susceptible (S) or infectious (I) compartment. The proportion of population that is infectious at time t is denoted by It=¯θθ=0ˇϕθitθ, which is defined in an analogous manner as its counterpart Yt with prior immunity. Table 3 gives a list of the variables, indices and parameters used in SIRWY model, comparing terms with/without prior immunity whenever possible. The SIRWY model is described by the following system of difference equations,

    Ft=ˇft+ft=¯θθ=0ˇξθˇϕθitθ+¯θθ=0˜ττ=2ξθϕθytθ,τ(1χτ)St+1=Stit+1it+1=StFtRt+1,0=¯θθ=0(ˇϕθˇϕθ+1)itθ+¯θθ=0(ϕθϕθ+1)ytθRt+1,τ=ζτRt(τ1),0for τ{1,,¯τ}Wt+1,1=(ζ0ζ1)Rt,0Wt+1,τ=Wt,τ1yt+1,τ+(ζτ1ζτ)Rt(τ1),0for τ{2,,¯τ+1}Wt+1,τ=Wt,τ1yt+1,τfor τ{¯τ+2,,˜τ1}Wt+1,˜τ=Wt,˜τ1+Wt,˜τyt+1,˜τyt+1,τ=(1ατ1)Wt,τ1Ftfor τ{2,,˜τ1}yt+1,˜τ=[(1α˜τ1)Wt,˜τ1+(1α˜τ)Wt,˜τ]Ft (A.1)
    Figure 4.  Susceptible-Infectious-Immune-Waned-Infectious (SIRWY) model.
    Table 3.  Variables, indices and parameters of the SIRWY model.
    Without With Terms without/with prior immunity Symbol Other terms
    ˇf f force of infection F total force of infection
    S W susceptible R immune
    i y newly infected θ time since infection
    I Y infectious ¯θ+1 max infectious period
    ˇϕθ ϕθ fraction still infectious τ time since recovery
    ˇξθ ξθ infectiousness ¯τ+1 max immune period
    ˜τ max value of τ
    ζτ fraction still immune
    χτ reduction in infectiousness
    ατ reduction in susceptibility

     | Show Table
    DownLoad: CSV

    and the conservation of individuals means that

    St+It+Rt+Wt+Yt=1. (A.2)

    The I, R, W and Y compartments can be defined in terms of their corresponding sub-compartments (see Table 4). Similar to the RWY model, the SIRWY model is specified using the proportion of newly infecteds (i and y) rather than the proportion of infectious individuals (I and Y).

    Table 4.  Definition of variables in the SIRWY model. The indices t, τ and θ refer to the time, time since recovery and time since infection respectively. The summations correspond to the max infectious period (¯θ+1), the max immune period (¯τ+1) and the max value of τ (˜τ).
    Symbol Variable Composition
    It infectious (without prior immunity) It=¯θθ=0ˇϕθitθ
    Rt immune Rt=¯ττ=0Rt,τ or Rt=¯ττ=0ζτRtτ,0
    Wt waned Wt=˜ττ=1Wt,τ
    Yt infectious (with prior immunity) Yt=˜ττ=2Yt,τ or Yt=¯θθ=0ϕθytθ
    yt newly infected (with prior immunity) yt=˜ττ=2yt,τ

     | Show Table
    DownLoad: CSV

    For a kth order difference equation, we define the following characteristic polynomial:

    p(λ)=λk+pk1λk1++p1λ+p0, (B.1)

    where pi are real numbers in our case.

    Definition B.1 (Inners of a matrix). (Jury, 1971 [26], Jury, 1974 [27] and Elaydi, 2005 [28]) The inners of a matrix B=(bij) are the matrix itself and all the matrices obtained by sequentially removing the first and last rows and the first and last columns. For example, other than the matrix itself, the inners of the following matrices are indicated by boxes:

    Definition B.2 (Postive Innerwise). (Jury, 1971 [26], Jury, 1974 [27] and Elaydi, 2005 [28]) A matrix B is positive innerwise if the determinants of all of its inners are positive.

    Theorem B.3 (Determinantal Criterion, a special case of Schur-Cohn Criterion). (Jury, 1964 [29], Jury, 1971 [26], Jury, 1974 [27] and Elaydi, 2005 [28]) The zeroes of the characteristic polynomial (equation B.1) lie inside the unit disc if and only if the following hold:

    (i) p(1)>0

    (ii) (1)kp(1)>0

    (iii) The (k1) by (k1) matrices

    B±k1=(100000pk110000pk2pk11000p4p5p6100p3p4p5pk110p2p3p4pk2pk11)±(00000p00000p0p1000p0p1p200p0pk6pk5pk40p0p1pk5pk4pk3p0p1p2pk4pk3pk2)

    are positive innerwise.

    Corollary B.4. (Eladyi, 2005 [28]) The three criteria in the Determinantal Criterion have an explicit form for lower orders.

    For k=2,

    |p1|<1+p0<2. (B.2)

    For k=3,

    |p2+p0|<1+p1and|p1p2p0|<1p20. (B.3)

    In the event that equation B.1 is of the following form with only 2 parameters:

    p(λ)=λk+ak1i=iλi+b, (B.4)

    we have an explicit form for the necessary and sufficient conditions for asymptotic stability.

    Theorem B.5. (Tomášek, 2015 [30]) Let a and b be real non-zero constants and k2. The zeroes of the characteristic polynomial (equation B.4) lie inside the unit disc if and only if

    (i) b>a1

    (ii) b<1

    (iii) b>(1k)a1.

    Theorem B.6 (Sufficient condition for stability). (Eladyi, 2005 [28]) The zeroes of the characteristic polynomial (equation B.1) lie inside the unit disc if

    k1i=0|pi|<1. (B.5)

    Lemma B.7 (Necessary conditions for stability). (Bistritz, 1984 [31]) If the zeroes of the characteristic polynomial (equation B.1) lie inside the unit disc, then the following hold:

    (i) |p0|<1

    (ii) p(1)>0

    (iii) (1)kp(1)>0.

    Theorem B.8. (Botta et al., 2014 [32]) The zeroes of the polynomial p(λ)=λk+a(λk1++λ)+1, aR, of degree k>1 lie on the unit circle if and only if

    (i) 2k1a2 if k is even

    (ii) 2k1a2+2k1 if k is odd.

    We first start from the following discrete time dynamical system (map) given by

    xf(x,ω),xRn,ωR1. (C.1)

    To perform a bifurcation analysis on the fixed point x at the critical parameter value ω, we do a coordinate shift, placing the fixed point at the origin. Now, in the new coordinates, after renaming and keeping the same variable x, we assume that this system can be written in the form

    ˜x=Jx+F(x),xRn, (C.2)

    where J is the Jacobian matrix and F(x) is a smooth function of order O(||x||2) with the following Taylor expansion

    F(x)=12K(x,x)+16L(x,x,x)+O(||x||4). (C.3)

    Here, K(x,y) and L(x,y,z) are defined by

    Ki(x,y)=nj,k=12Fi(s)sjsk|s=0xjyk (C.4)

    and

    Li(x,y,z)=nj,k,l=13Fi(s)sjsksl|s=0xjykzl (C.5)

    for i=1,,n. This presentation and subsequent results in this section are attributed to Kuznetsov, 2004 [33].

    Here, assume that the Jacobian J has a simple eigenvalue 1 on the unit circle. The map (equation C.2), when restricted to the center manifold, can be transformed to the normal form

    ˜y=y+by3+O(y4), (C.6)

    where b gives the direction of bifurcation of the period-two cycle and can be computed using the following invariant formula:

    b=16p,L(q,q,q)12p,K(q,(JI)1K(q,q)). (C.7)

    In this case, q is the real eigenvector satisfying Jq=q while p is the real adjoint eigenvector satisfying JTp=p. The eigenvectors p and q have been normalized such that p,q=1. Functions K(x,y) and L(x,y,z) are as defined in equation C.4 and C.5 respectively.

    If b>0, then a stable period-two cycle bifurcates from the fixed point for parameter values ω larger than the critical parameter value ω. When b<0, then the cycle of period-two is unstable. The case of b=0 means that the bifurcation is more degenerate than the normal form.

    Assuming that the Jacobian J has a simple pair of eigenvalues on the unit circle e±iθ0, where θ0(0,π) and these are the only eigenvalues with modulus 1. The absence of strong resonances means that eikθ01 for k{1,2,3,4}. Then, the map (equation C.2) can be restricted to the center manifold and transformed to the complex normal form

    ˜z=eiθ0z(1+d1|z|2)+O(|z|4), (C.8)

    where d=Re d1 gives the direction of the closed invariant curve and can be computed using the following invariant expression

    d=12Re{eiθ0[p,L(q,q,¯q)+2p,K(q,(IJ)1K(q,¯q))+p,K(¯q,(e2iθ0IJ)1K(q,q))]}. (C.9)

    Here, q is the complex eigenvector satisfying Jq=eiθ0q and J¯q=eiθ0¯q while p is the complex adjoint eigenvector satisfying JTp=eiθ0p and JT¯p=eiθ0¯p. The scalar product p,q=¯pTq is the standard one in Cn; p and q have been normalized such that p,q=1. Functions K(x,y) and L(x,y,z) are as defined in equation C.4 and C.5 respectively.

    If d<0, then a stable closed invariant curve bifurcates from the fixed point for parameter values ω larger than the critical parameter value ω. When d>0, then the closed invariant curve is unstable. The case of d=0 means that the bifurcation is more degenerate than the normal form.

    In this case, Jacobian J has eigenvalues e±iπ2=±i and the map (equation C.2) can be transformed to the following complex normal form

    ˜z=iz+bz|z|2+d¯z3+O(|z|4), (C.10)

    where

    b=12p,L(q,q,¯q)+2K(q,(IJ)1K(q,¯q))K(¯q,(I+J)1K(q,q)) (C.11)

    and

    d=16p,L(¯q,¯q,¯q)3K(¯q,(I+J)1K(¯q,¯q)). (C.12)

    As before, the terms K, L, p and q are as defined in the previous section where there is an absence of strong resonances.



    [1] A. K. Chakraborty, A. Kosmrlj, Statistical mechanical concepts in immunology, Annu. Rev. Phys. Chem., 61 (2010), 283–303. https://doi.org/10.1146/annurev.physchem.59.032607.093537 doi: 10.1146/annurev.physchem.59.032607.093537
    [2] P. Nieuwenhuis, D. Opstelten, Functional anatomy of germinal centers, Dev. Dynam., 170 (1984), 421–435. https://doi.org/10.1002/aja.1001700315 doi: 10.1002/aja.1001700315
    [3] D. M. Tarlinton, K. G. C. Smith, Dissecting affinity maturation: a model explaining selection of antibody-forming cells and memory b cells in the germinal centre, Immunol. Today, 21 (2000), 436–441. https://doi.org/10.1016/S0167-5699(00)01687-X doi: 10.1016/S0167-5699(00)01687-X
    [4] I. C. Maclennan, Germinal centers, Annu. Rev. Immunol., 12 (1994), 117–139. https://doi.org/10.1146/annurev.immunol.12.1.117
    [5] T. A. Schwickert, R. L. Lindquist, G. Shakhar, G. Livshits, M. C. Nussenzweig, in vivo imaging of germinal centres reveals a dynamic open structure, Nature, 446 (2007), 83–87. https://doi.org/10.1038/nature05573 doi: 10.1038/nature05573
    [6] Y. Natkunam, The biology of the germinal center, Hematology, 2007 (2007), 210–215. https://doi.org/10.1182/asheducation-2007.1.210 doi: 10.1182/asheducation-2007.1.210
    [7] C. D. C. Allen, T. Okada, H. Tang, J. G. Cyster, Imaging of germinal center selection events during affinity maturation, Science, 315 (2007), 528–531. https://doi.org/10.1126/science.1136736 doi: 10.1126/science.1136736
    [8] G. D. Victora, M. C. Nussenzweig, Germinal centers, Annu. Rev. Immunol., 30 (2012), 429–457. https://doi.org/10.1146/annurev-immunol-020711-075032
    [9] A. S. Perelson, G. F. Oster, Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination, J. Theor. Biol., 81 (1979), 645–670. https://doi.org/10.1016/0022-5193(79)90275-3 doi: 10.1016/0022-5193(79)90275-3
    [10] T. B. Kepler, A. S. Perelson, Cyclic re-entry of germinal center B cells and the efficiency of affinity maturation, Immunol. Today, 14 (1993), 412–415. https://doi.org/10.1016/0167-5699(93)90145-B doi: 10.1016/0167-5699(93)90145-B
    [11] A. S. Perelson, G. Weisbuch, Immunology for physicists, Rev. Mod. Phys., 69 (1997), 1219–1267. https://doi.org/10.1103/RevModPhys.69.1219 doi: 10.1103/RevModPhys.69.1219
    [12] M. Oprea, Somatic mutation leads to efficient affinity maturation when centrocytes recycle back to centroblasts, J. Immunol., 158(1997), 5155–5162. https://doi.org/10.1016/S0165-2478(97)85162-0 doi: 10.1016/S0165-2478(97)85162-0
    [13] S. Erwin, S. M. Ciupe, Germinal center dynamics during acute and chronic infection, Math. Biosci. Eng., 14 (2017), 655–671. https://doi.org/10.3934/mbe.2017037 doi: 10.3934/mbe.2017037
    [14] M. Meyer-Hermann, M. T. Figge, K. M. Toellner, Germinal centres seen through the mathematical eye: B-cell models on the catwalk, Trends Immunol., 30 (2009), 157–164. https://doi.org/10.1016/j.it.2009.01.005 doi: 10.1016/j.it.2009.01.005
    [15] L. Buchauer, H. Wardemann, Calculating germinal centre reactions, Curr. Opin. Syst. Biol., 18 (2019), 1–8. https://doi.org/10.1016/j.coisb.2019.10.004 doi: 10.1016/j.coisb.2019.10.004
    [16] M. J. Shlomchik, F. Weisel, Germinal center selection and the development of memory B and plasma cells, Immunol. Rev., 247 (2012), 52–63. https://doi.org/10.1111/j.1600-065X.2012.01124.x doi: 10.1111/j.1600-065X.2012.01124.x
    [17] M. Meyer-Hermann, P. K. Maini, Interpreting two-photon imaging data of lymphocyte motility, Phys. Rev. E, 71 (2005), 061912. https://doi.org/10.1103/PhysRevE.71.061912 doi: 10.1103/PhysRevE.71.061912
    [18] M. T. Figge, A. Garin, M. Gunzer, M. Kosco-Vilbois, K. M. Toellner, M. Meyer-Hermann, Deriving a germinal center lymphocyte migration model from two-photon data, J. Exp. Med., 205 (2008), 3019–3029. https://doi.org/10.1084/jem.20081160 doi: 10.1084/jem.20081160
    [19] T. Beyer, M. Meyer-Hermann, G. Soff, A possible role of chemotaxis in germinal center formation, Int. Immunol., 14 (2003), 1369–1381. https://doi.org/10.1016/j.celrep.2012.05.010 doi: 10.1016/j.celrep.2012.05.010
    [20] M. Meyer-Hermann, A mathematical model for the germinal center morphology and affinity maturation, J. Theor. Biol., 216 (2002), 273–300. https://doi.org/10.1016/j.coisb.2019.10.004 doi: 10.1016/j.coisb.2019.10.004
    [21] M. Meyer-Hermann, A concerted action of b cell selection mechanisms, Adv. Complex. Syst., 10 (2007), 557–580. https://doi.org/10.1142/S0219525907001276 doi: 10.1142/S0219525907001276
    [22] S. Crotty, T follicular helper cell biology: A decade of discovery and diseases, Immunity, 50 (2019), 1132–1148. https://doi.org/10.1016/j.immuni.2019.04.011 doi: 10.1016/j.immuni.2019.04.011
    [23] M. Meyer-Hermann, P. K. Maini, A. D. Iber, An analysis of B cell selection mechanisms in germinal centres, Math. Med. Biol., 23 (2006), 255–277. https://doi.org/10.1007/s11538-009-9408-8 doi: 10.1007/s11538-009-9408-8
    [24] M. J. Thomas, U. Klein, J. Lygeros, M. R. Martínez, A probabilistic model of the germinal center reaction, Front. Immunol., 10 (2019). https://doi.org/10.3389/fimmu.2019.00689
    [25] M. Meyer-Hermann, E. Mohr, N. Pelletier, Y. Zhang, G. D. Victora, K. M. Toellner, A theory of germinal center B cell selection, division, and exit, Cell Rep., 2 (2012), 162–174. https://doi.org/10.1016/j.celrep.2012.05.010 doi: 10.1016/j.celrep.2012.05.010
    [26] P. A. Robert, A. L. Marschall, M. Meyer-Hermann, Induction of broadly neutralizing antibodies in germinal centre simulations, Curr. Opin. Biotechnol., 51 (2018), 137–145. https://doi.org/10.1016/j.copbio.2018.01.006 doi: 10.1016/j.copbio.2018.01.006
    [27] M. Molari, K. Eyer, J. Baudry, S. Cocco, R. Monasson, Quantitative modeling of the effect of antigen dosage on b-cell affinity distributions in maturating germinal centers, Elife, 9 (2020). https://doi.org/10.7554/elife.55678
    [28] E. M. Tejero, D. Lashgari, R. García-Valiente, X. Gao, F. Crauste, P. A. Robert, et al., Multiscale modeling of germinal center recapitulates the temporal transition from memory B cells to plasma cells differentiation as regulated by antigen affinity-based tfh cell help, Front. Immunol., 11 (2021). https://doi.org/10.3389/fimmu.2020.620716
    [29] S. Wang, J. Mata-Fink, B. Kriegsman, M. Hanson, D. Irvine, H. Eisen, et al., Manipulating the selection forces during affinity maturation to generate cross-reactive hiv antibodies, Cell, 160 (2015), 785–797. https://doi.org/10.1016/j.cell.2015.01.027 doi: 10.1016/j.cell.2015.01.027
    [30] N. Wittenbrink, T. S. Weber, A. Klein, A. A. Weiser, W. Zuschratter, M. Sibila, et al., Broad volume distributions indicate nonsynchronized growth and suggest sudden collapses of germinal center B cell populations, J. Immunol., 184 (2010), 1339–1347. https://doi.org/10.4049/jimmunol.0901040 doi: 10.4049/jimmunol.0901040
    [31] N. Wittenbrink, A. Klein, A. A. Weiser, J. Schuchhardt, M. Or-Guil, Is there a typical germinal center? a large-scale immunohistological study on the cellular composition of germinal centers during the hapten-carrier-driven primary immune response in mice, J. Immunol., 187 (2011), 6185–6196. https://doi.org/10.4049/jimmunol.1101440 doi: 10.4049/jimmunol.1101440
    [32] P. Wang, C. M. Shih, H. Qi, Y. H. Lan, A stochastic model of the germinal center integrating local antigen competition, individualistic T-B interactions, and B cell receptor signaling, J. Immunol., 197 (2016), 1169–1182. https://doi.org/10.4049/jimmunol.1600411 doi: 10.4049/jimmunol.1600411
    [33] D. T. Gillespie, Exact stochastic simulation of coupled chemical-reactions, J. Phys. Chem., 81 (1977), 2340–2361. https://doi.org/10.1021/j100540a008 doi: 10.1021/j100540a008
    [34] A. D. Gitlin, C. T. Mayer, T. Y. Oliveira, Z. Shulman, M. J. K. Jones, A. Koren, et al., T cell help controls the speed of the cell cycle in germinal center B cells, Science, 349 (2015), 643–646. https://doi.org/10.1126/science.aac4919 doi: 10.1126/science.aac4919
    [35] H. Qi, J. G. Egen, A. Y. C. Huang, R. N. Germain, Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells, Science, 312 (2006), 1672–1676. https://doi.org/10.1126/science.1125703 doi: 10.1126/science.1125703
    [36] H. Qi, J. L. Cannons, F. Klauschen, P. L. Schwartzberg, R. N. Germain, Sap-controlled T-B cell interactions underlie germinal centre formation, Nature, 455 (2008), 764–769. https://doi.org/10.1038/nature07345 doi: 10.1038/nature07345
    [37] J. G. Cyster, Chemokines and cell migration in secondary lymphoid organs, Science, 286 (1999), 2098–2102. https://doi.org/10.1126/science.286.5447.2098 doi: 10.1126/science.286.5447.2098
    [38] H. Qi, X. Chen, C. Chu, P. Lu, H. Xu, J. Yan, Follicular t-helper cells: controlled localization and cellular interactions, Immunol. Cell Biol., 92 (2014), 28–33. https://doi.org/10.1038/icb.2013.59 doi: 10.1038/icb.2013.59
    [39] H. Qi, W Kastenmüller, R. N. Germain, Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue, Annu. Rev. Cell Dev. Biol., 30 (2014), 141–167. https://doi.org/10.1146/annurev-cellbio-100913-013254 doi: 10.1146/annurev-cellbio-100913-013254
    [40] Z. Shulman, A. D. Gitlin, S. Targ, M. Jankovic, G. Pasqual, M. C. Nussenzweig, et al., T follicular helper cell dynamics in germinal centers, Science, 341 (2013), 673–677. https://doi.org/10.1126/science.1241680 doi: 10.1126/science.1241680
    [41] J. S. Shaffer, P. L. Moore, M. Kardar, A. K. Chakraborty, Optimal immunization cocktails can promote induction of broadly neutralizing abs against highly mutable pathogens, PNAS, 113 (2016), 7039–7048. https://doi.org/10.1073/pnas.1614940113 doi: 10.1073/pnas.1614940113
    [42] B. J. C. Quah, V. P. Barlow, V. Mcphun, K. I. Matthaei, M. D. Hulett, C. R. Parish, Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer, PNAS, 105 (2008), 4259–4264. https://doi.org/10.1073/pnas.0800259105 doi: 10.1073/pnas.0800259105
    [43] O. Bannard, R. Horton, C. C. Allen, J. An, T. Nagasawa, J. Cyster, Germinal center centroblasts transition to a centrocyte phenotype according to a timed program and depend on the dark zone for effective selection, Immunity, 39 (2013), 1182. https://doi.org/10.1016/j.immuni.2013.11.006 doi: 10.1016/j.immuni.2013.11.006
    [44] D. Liu, H. Xu, C. M. Shih, Z. Wan, X. P. Ma, W. Ma et al., T–B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction, Nature, 517 (2015), 214–218. https://doi.org/10.1038/nature13803 doi: 10.1038/nature13803
    [45] J. Shi, S. Hou, Q. Fang, X. Liu, X. Liu, H. Qi, Pd-1 controls follicular t helper cell positioning and function, Immunity, 49 (2018), 264–274. https://doi.org/10.1016/j.immuni.2018.06.012 doi: 10.1016/j.immuni.2018.06.012
    [46] J. Jacob, R. Ksssir, G. Kelsoe, In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. I. the architecture and dynamics of responding cell populations, J. Exp. Med., 173 (1991), 1165–1175. https://doi.org/10.1084/jem.173.5.1165 doi: 10.1084/jem.173.5.1165
    [47] F. Kroese, A. S. Wubbena, H. G. Seijen, P. Nieuwenhuis, Germinal centers develop oligoclonally, Eur. J. Immunol., 17 (1987), 1069–1072. https://doi.org/10.1002/eji.1830170726 doi: 10.1002/eji.1830170726
    [48] A. Lapedes, R. Farber, The geometry of shape space: application to influenza, J. Theor. Biol., 212 (2001), 57–69. https://doi.org/10.1006/jtbi.2001.2347 doi: 10.1006/jtbi.2001.2347
    [49] G. Kelsoe, The germinal center: a crucible for lymphocyte selection, Semin. Immunol., 8 (1996), 179–184. https://doi.org/10.1006/smim.1996.0022 doi: 10.1006/smim.1996.0022
    [50] M. J. Miller, S. H. Wei, I. Parker, M. D. Cahalan, Two-photon imaging of lymphocyte motility and antigen response in intact lymph node, Science, 296 (2002), 1869–1873. https://doi.org/10.1126/science.1070051 doi: 10.1126/science.1070051
    [51] S. H. Wei, I. Parker, M. J. Miller, M. D. Cahalan, A stochastic view of lymphocyte motility and trafficking within the lymph node, Immunol. Rev., 195 (2003), 136–159. https://doi.org/10.1034/j.1600-065x.2003.00076.x doi: 10.1034/j.1600-065x.2003.00076.x
    [52] Y. J. Liu, J. Zhang, P. J. L. Lane, Y. T. Chan, I. C. M. Maclennan, Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens, Eur. J. Immunol., 21 (1991), 2951–2962. https://doi.org/10.1002/eji.1830211209 doi: 10.1002/eji.1830211209
    [53] S. Han, In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. IV. affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance, J. Exp. Med., 182 (1995), 1635–1644. https://doi.org/10.1084/jem.173.5.1165 doi: 10.1084/jem.173.5.1165
    [54] C. D. C. Allen, T. Okada, J. G. Cyster, Germinal center organization and cellular dynamics, Immunity, 27 (2007), 190–202. https://doi.org/10.1016/j.immuni.2007.07.009 doi: 10.1016/j.immuni.2007.07.009
    [55] S. A. Camacho, M. H. Kosco-Vilbois, C. Berek, The dynamic structure of the germinal center, Immunol. Today, 19 (1998), 511–514. https://doi.org/10.1016/S0167-5699(98)01327-9 doi: 10.1016/S0167-5699(98)01327-9
    [56] N. S. De Silva, U. Klein, Dynamics of B cells in germinal centres, Nat. Rev. Immunol., 15 (2015), 137–148. https://doi.org/10.1038/nri3804 doi: 10.1038/nri3804
    [57] C. T. Mayer, A. Gazumyan, E. E. Kara, A. D. Gitlin, J. Golijanin, C. Viant, et al., The microanatomic segregation of selection by apoptosis in the germinal center, Science, 358 (2017). https://doi.org/10.1126/science.aao2602
    [58] J. M. J. Tas, L. Mesin, G. Pasqual, S. Targ, J. T. Jacobsen, Y. M. Mano, et al., Visualizing antibody affinity maturation in germinal centers, Science, 351 (2016), 1048–1054. https://doi.org/10.1126/science.aad3439 doi: 10.1126/science.aad3439
    [59] R. Murugan, L. Buchauer, G. Triller, C. Kreschel, H. Wardemann, Clonal selection drives protective memory B cell responses in controlled human malaria infection, Sci. Immunol., 3 (2018). https://doi.org/10.1126/sciimmunol.aap8029
    [60] K. Kwak, N. Quizon, H. Sohn, A. Saniee, J. Manzella-Lapeira, P. Holla, et al., Intrinsic properties of human germinal center B cells set antigen affinity thresholds, Sci. Immunol., 3 (2018). https://doi.org/10.1126/sciimmunol.aau6598
    [61] T. A. Schwickert, G. D. Victora, D. R. Fooksman, A. O. Kamphorst, M. R. Mugnier, A. D. Gitlin, et al., A dynamic t cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center, J. Exp. Med., 208 (2011), 1243–1252. https://doi.org/10.1084/jem.20102477 doi: 10.1084/jem.20102477
    [62] M. Meyer-Hermann, T. Beyer, Conclusions from two model concepts on germinal center dynamics and morphology, Dev. immunol., 9 (2002), 203–214. https://doi.org/10.1080/1044-6670310001597060 doi: 10.1080/1044-6670310001597060
    [63] P. A. Robert, T Arulraj, M. Meyer-Hermann, Ymir: A 3d structural affinity model for multi-epitope vaccine simulations, IScience, 24 (2021), 102979. https://doi.org/10.1016/j.isci.2021.102979 doi: 10.1016/j.isci.2021.102979
  • This article has been cited by:

    1. Min-Jia Hsieh, Ping-Hsing Tsai, Pin-Hsuan Chiang, Zih-Kai Kao, Zi-Qing Zhuang, Ai-Ru Hsieh, Hsiang-Ling Ho, Shih-Hwa Chiou, Kung-Hao Liang, Yu-Chun Chen, Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity, 2024, 20, 2164-5515, 10.1080/21645515.2024.2399382
  • Reader Comments
  • © 2022 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2590) PDF downloads(111) Cited by(0)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog